S'abonner

Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines - 12/05/16

Doi : 10.1016/j.ahj.2016.01.008 
Robin Mathews, MD a, , Gregg C. Fonarow, MD b, Shuang Li, MS a, Eric D. Peterson, MD, MPH a, John S. Rumsfeld, MD, PhD c, Paul A. Heidenreich, MD d, Matthew T. Roe, MD, MHS a, William J. Oetgen, MD, MBA e, James G. Jollis, MD a, Christopher P. Cannon, MD f, James A. de Lemos, MD g, Tracy Y. Wang, MD, MHS, MSc a
on behalf of the

National Cardiovascular Data Registry

a Duke Clinical Research Institute/Duke University Medical Center, Durham, NC 
b Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, CA 
c Denver VA Medical Center, Denver, CO 
d VA Palo Alto Health System, Palo Alto, CA 
e American College of Cardiology, Washington, DC 
f Brigham and Women's Hospital, Boston, MA 
g University of Texas–Southwestern Medical Center, Dallas, TX 

Reprint requests: Robin Mathews, MD, Duke University Medical Center, 2400 Pratt Street, Durham, NC 27705.Duke University Medical Center2400 Pratt StreetDurhamNC27705

Résumé

Background

Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines (ACTION Registry–GWTG) was designed to measure and improve the treatment and outcomes of patients with acute myocardial infarction (AMI), yet it is unknown whether performance of Medicare Hospital Compare metrics and outcomes differ between hospitals participating versus those not participating in the registry.

Methods

Using 2007 to 2010 Hospital Compare data, we matched participating to nonparticipating hospitals based on teaching status, size, percutaneous coronary intervention capability, and baseline (2007) Hospital Compare AMI process measure performance. We used linear mixed modeling to compare 2010 Hospital Compare process measure adherence, 30-day risk-adjusted mortality, and readmission rates. We repeated these analyses after stratification according to baseline performance level.

Results

Compared with nonparticipating hospitals, those participating were larger (median 288 vs 139 beds, P < .0001), more often teaching hospitals (18.8% vs 6.3%, P < .0001), and more likely had interventional catheterization lab capabilities (85.7% vs 34.0%, P < .0001). Among 502 matched pairs of participating and nonparticipating hospitals, we found high levels of process measure adherence in both 2007 and 2010, with minimal differences between them. Rates of 30-day mortality and readmission in 2010 were also similar between both groups. Results were consistent across strata of baseline performance level.

Conclusions

In this observational analysis, there were no significant differences in the performance of Hospital Compare process measures or outcomes between hospitals in Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines and other hospitals not in the registry. However, baseline performance on the Hospital Compare process measures was very high in both groups, suggesting the need for new quality improvement foci to further improve patient outcomes.

Le texte complet de cet article est disponible en PDF.

Plan


 Paul W. Armstrong, MD, served as guest editor for this article.


© 2016  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 175

P. 1-8 - mai 2016 Retour au numéro
Article précédent Article précédent
  • The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China
  • Haiyan Xu, Wei Li, Jingang Yang, Stephen D. Wiviott, Marc S. Sabatine, Eric D. Peterson, Ying Xian, Matthew T. Roe, Wei Zhao, Yang Wang, Xinran Tang, Xuan Jia, Yuan Wu, Runlin Gao, Yuejin Yang, CAMI Registry study group
| Article suivant Article suivant
  • Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation
  • Jason D. Roberts, Thomas A. Dewland, David V. Glidden, Thomas J. Hoffmann, Dan E. Arking, Lin Y. Chen, Bruce M. Psaty, Jeffrey E. Olgin, Alvaro Alonso, Susan R. Heckbert, Gregory M. Marcus

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.